Please assess the completion status of the following clinical trial:

Trial Title: Steroid Delivery to the Frontal Sinus Opening With a Bioabsorbable Implant vs. a Bioabsorbable Nasal Dressing

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Adults aged 18 and older~* Diagnosis of chronic rhinosinusitis with nasal polyps based on the American Academy of Otolaryngology-Head and Neck Surgery guidelines~* Patient scheduled for bilateral endoscopic sinus surgery with evidence of bilateral frontal sinus disease based on Computed Tomography (Lund-Mackay score greater than or equal to 1)~* At the time of surgery bilateral frontal sinusotomy of type Draf 2a or 2b was performed using the same technique on both sides~* Bilateral endoscopic sinus surgery performed successfully without complication~* Frontal sinus opening diameter greater than 4.0 mm achieved (4 mm olive tipped suction easily passed into frontal sinus)~Exclusion Criteria:~* Any patient who had frontal sinus surgery for tumor~* Allergy to mometesone and/or triamcinolone~* Frontal sinusotomy type Draf 1 or Draf 3 performed~* One or both frontal sinus openings not amenable to implant placement~* Patients with chronic oral steroid dependent conditions~* Invasive fungal sinusitis~* Immune deficiency

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Bioabsorbable steroid releasing sinus implant & nasal dressing impregnated with steroid (Type: EXPERIMENTAL): Patients will undergo bilateral endoscopic sinus surgery which will include bilateral frontal sinusotomy of Draf 2a or 2b type as previously described in the literature. At the conclusion of the procedure, if the patient still meets all inclusion criteria, one frontal sinus will be randomly assigned using the envelop method to receive a bioabsorbable steroid releasing implant and the other frontal sinus will receive a bioabsorbable nasal dressing impregnated with steroid

Based on this trial design, predict the completion outcome and termination type (if applicable).